Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis

Area of Science:

• Neuroimmunology
• Cellular and Molecular Neuroscience
• Oligodendrocyte Biology

Background:

• Multiple sclerosis (MS) involves immune attack on myelin, produced by oligodendrocytes (OLs).
• The role of OL lineage cells in MS pathogenesis is traditionally viewed as passive targets.

Purpose of the Study:

• To investigate the function and characteristics of OL lineage cells during experimental autoimmune encephalomyelitis (EAE), a model for MS.
• To identify disease-specific OL populations and their molecular signatures in both mouse models and human MS brains.

Main Methods:

• Single-cell transcriptomic analysis of OL lineage cells from EAE mouse spinal cords.
• Comparative analysis of gene expression in healthy versus EAE-induced OLs and OL precursor cells (OPCs).
• Investigation of OPC phagocytic activity and T cell activation capabilities.

Main Results:

• Unique OL and OPC populations with distinct gene expression profiles were identified in EAE.
• EAE-specific OL lineage cells express genes for antigen processing/presentation (MHC-I, -II) and immunoprotection.
• Disease-associated oligodendroglia and MS susceptibility genes are found in OL lineage cells in human MS brains.
• OPCs demonstrate phagocytosis and MHC-II-expressing OPCs activate CD4+ T cells.

Conclusions:

• OLs and OPCs are active immunomodulators in MS, not merely passive targets.
• Disease-specific OL lineage cells possess unique biomarkers and functional capacities.
• These findings suggest novel therapeutic strategies targeting OL lineage cells in MS.